Prognostic value of the pre-treatment albumin-to-alkaline phosphatase ratio in patients with lower-grade glioma: a propensity score matching study
Pre-treatment AAPR is a simple, non-invasive, and effective biomarker for predicting prognosis in LGG patients, particularly those at lower clinical risk.
Authors
- Dae-Young Zang
- Lingjuan Li (ORCID: https://orcid.org/0000-0002-3379-4295)
- Xiaoming Huang (ORCID: https://orcid.org/0000-0002-3126-5576)
Institutions
- Fudan University (CN)
- China-Japan Friendship Hospital (CN)
- Huashan Hospital (CN)
- Shanghai Center for Brain Science and Brain-Inspired Technology (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-07-16
- DOI
- https://doi.org/10.3389/fphar.2025.1556108
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China-Japan Friendship Hospital